2026-08-29
$2M of new funding is targeting oil gas and pipeline operations
1 funded company building into oil gas and pipeline operations. The work in scope is what the Head of Upstream Operations owns today.
The funding
Advancing Non-Systemic Medicines for Inflammatory Skin Diseases Turn Therapeutics develops first-in-class topical therapies that act within the skin to prevent unnecessary immune activation without systemic exposure or injections. Explore GX-03 Explore Pipeline Turn Therapeutics is a clinical-stage biotechnology company advancing first-in-class therapies designed to act where disease occurs, not w
Turn Therapeutics Inc. Form D filing →What it means
Capital arriving in a function is a reliable leading indicator. It does not mean the incumbents are wrong, and it does not mean these companies will succeed. It means that within the next few quarters the people who run this work will be asked what their function is doing about it, and the honest answer has to start with where that function actually stands.
So we built the assessment for it. Not a purchase decision, a structured set of questions to take to your own team.